Lantern Pharma Inc. (LTRN) › Shareholders' EquityLantern Pharma Inc. (LTRN) — Shareholders' EquityAnnual figures by period end, from SEC filings.2018-12-31: -$201.8K2019-12-31: $943.3K2020-12-31: $19.70M2021-12-31: $71.57M2022-12-31: $56.04M2023-12-31: $40.91M2024-12-31: $21.19M2025-12-31: $6.53M$6.53M2018-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$6.53M-69.2%2026-03-30Balance as of period end2024-12-31$21.19M-48.2%2026-03-30Balance as of period end2023-12-31$40.91M-27.0%2026-03-30Balance as of period end2022-12-31$56.04M-21.7%2025-03-27Balance as of period end2021-12-31$71.57M+263.3%2024-03-18Balance as of period end2020-12-31$19.70M+1988.3%2023-03-20Balance as of period end2019-12-31$943.3K—2022-03-10Balance as of period end2018-12-31-$201.8K—2021-03-10Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)